Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,060

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/freshpoint-issues-recall-due-improperly-declared-allergen-egg-chicken-salad-wedge-sandwichesPublished September 8, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 9, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Ongoing Historical recordClass II

Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01

by Safecor Health, LLC

Reason: cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-104-01

by Safecor Health, LLC

Reason: cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 68180-589-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1

by Tailstorm Health INC

Reason: Lack of Sterility Assurance
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Guaifenesin Dextromethorphan Syrup, 100 mg/10mg per 5 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7134-70

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Failed Impurity/Degradation Specifications
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Guaifenesin Dextromethorphan Syrup, 200 mg/20mg per 10 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7135-72

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Failed Impurity/Degradation Specifications
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05

by Padagis US LLC

Reason: Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Tablet/Capsule Specifications
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The JM Smucker Company LLC

Product: Great Value Cinnamon Rolls 16.5oz UPC 078742201160, 12 retai…
Reason: Pieces of plastic in product
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The JM Smucker Company LLC

Product: Great Value Cheese Danish 16.5 oz UPC 078742201177, 12 retai…
Reason: Pieces of plastic in product
Published: November 27, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution, Rx Only, Net Wt. 10 oz. (283.5 g) pumps, Mint flavor, Manufactured by: Keystone Industries, 480 S. Democrat Rd., Gibbstown, NJ 08027, NDC 68400-202-10

by Keystone Industries

Reason: Subpotent Drug
Published: November 20, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason: Failed Impurities/Degradation Specifications; during routine stability testing for impurities.
Published: November 20, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90

by Cipla USA, Inc.

Reason: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Published: November 20, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

by Cipla USA, Inc.

Reason: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Published: November 20, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009

by Trinity Gold Nutrition

Reason: Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.
Published: November 20, 2024
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Ibuprofen 800mg, Generic for: Motrin, Each tablet contains: Ibuprofen, USP 800 mg, Packaged and Distributed by: DIRECT Rx, Dawsonville, GA 30534, Mfg By: Dr. Reddy's Laboratories LA, LLC, Shreveport, LA 71106, a) NDC 61919-0621-15 (15 count bottles), b) NDC 61919-0621-30 (30 count bottles, c) NDC 61919-0621-40 (40 count bottles), d) NDC 61919-0621-60 (60 count bottles), e) NDC 61919-0621-90 (90 count bottles), f) NDC: 61919-0621-100 and NDC: 61919-0621-71 (100 count bottles), g) NDC 61919-0621-72 (120 count bottles).

by Direct Rx

Reason: Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.
Published: November 13, 2024
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

by Staska Pharmaceuticals, Inc.

Reason: Presence of Particulate Matter: Presence of glass particulates.
Published: November 13, 2024
Distribution: Nationwide

View recall →

Data last updated: September 9, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.